Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aurinia Pharmaceuticals
Fierce Pharma
George Tidmarsh exits as LinkedIn post sparks lawsuit, probe
A recent LinkedIn post has landed the now-departed CDER chief at the center of an Aurinia lawsuit and an internal probe.
Fraiser Kansteiner
Nov 3, 2025 11:13am
After hunt for buyer fails, Aurinia lays off 25%, drops R&D
Feb 15, 2024 8:25am
Aurinia pays $7M for 2 preclinical assets after January FDA nod
Aug 17, 2021 11:56am
Aurinia ditches would-be Restasis rival after phase 2/3 fail
Nov 2, 2020 5:05pm
Aurinia soars as phase 3 lupus study hits primary endpoint
Dec 5, 2019 7:30am